{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:54:43Z","timestamp":1781625283077,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772581"],"award-info":[{"award-number":["81772581"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271199"],"award-info":[{"award-number":["81271199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2020,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>We previously demonstrated that the pleomorphic adenoma gene like-2 (PLAGL2) is involved in the pathogenesis of Hirschsprung disease. Enhanced PLAGL2 expression was observed in several malignant tumours. However, the exact function of PLAGL2 and its underlying mechanism in colorectal cancer (CRC) remain largely unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Immunohistochemical analysis of PLAGL2 was performed. A series of in vitro and in vivo experiments were conducted to reveal the role of PLAGL2 in the progression of CRC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Enhanced PLAGL2 expression was significantly associated with EMT-related proteins in CRC. The data revealed that PLAGL2 promotes CRC cell proliferation, migration, invasion and EMT both in vitro and in vivo. Mechanistically, PLAGL2 promoted the expression of ZEB1. PLAGL2 enhanced the expression and nuclear translocation of \u03b2-catenin by decreasing its phosphorylation. The depletion of \u03b2-catenin neutralised the regulation of ZEB1 that was caused by enhanced PLAGL2 expression. The small-molecule inhibitor PNU-74654, also impaired the enhancement of ZEB1 that resulted from the modified PLAGL2 expression. The depletion of ZEB1 could block the biological function of PLAGL2 in CRC cells.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Collectively, our findings suggest that PLAGL2 mediates EMT to promote colorectal cancer metastasis via \u03b2-catenin-dependent regulation of ZEB1.<\/jats:p><\/jats:sec>","DOI":"10.1038\/s41416-019-0679-z","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:06:15Z","timestamp":1576109175000},"page":"578-589","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["PLAGL2 promotes epithelial\u2013mesenchymal transition and mediates colorectal cancer metastasis via \u03b2-catenin-dependent regulation of ZEB1"],"prefix":"10.1038","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9367-7368","authenticated-orcid":false,"given":"Liang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zili","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengbo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xudan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzheng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"679_CR1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3322\/caac.21395","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D., Fedewa, S. A., Ahnen, D. J., Meester, R., Barzi, A. et al. Colorectal cancer statistics, 2017. CA Cancer J. Clin. 67, 177\u2013193 (2017).","journal-title":"CA Cancer J. Clin."},{"key":"679_CR2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 69, 7\u201334 (2019).","journal-title":"CA Cancer J. Clin."},{"key":"679_CR3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer, C. L. & Weinberg, R. A. A perspective on cancer cell metastasis. Science 331, 1559\u20131564 (2011).","journal-title":"Science"},{"key":"679_CR4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871\u2013890 (2009).","journal-title":"Cell"},{"key":"679_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre, A. & Weinberg, R. A. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat. Rev. Mol. Cell Biol. 20, 69\u201384 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"679_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2011.03.029","volume":"145","author":"JP Sleeman","year":"2011","unstructured":"Sleeman, J. P. & Thiery, J. P. SnapShot: the epithelial-mesenchymal transition. Cell 145, 161\u2013162 (2011).","journal-title":"Cell"},{"key":"679_CR7","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420\u20131428 (2009).","journal-title":"J. Clin. Invest."},{"key":"679_CR8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/ncb3050","volume":"16","author":"Y Wang","year":"2014","unstructured":"Wang, Y., Bu, F., Royer, C., Serres, S., Larkin, J. R., Soto, M. S. et al. ASPP2 controls epithelial plasticity and inhibits metastasis through \u03b2-catenin-dependent regulation of ZEB1. Nat. Cell Biol. 16, 1092\u20131104 (2014).","journal-title":"Nat. Cell Biol."},{"key":"679_CR9","doi-asserted-by":"crossref","first-page":"19204","DOI":"10.1073\/pnas.1108977108","volume":"108","author":"E Sanchez-Tillo","year":"2011","unstructured":"Sanchez-Tillo, E., de Barrios, O., Siles, L., Cuatrecasas, M., Castells, A. & Postigo, A. \u03b2-catenin\/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumour invasiveness. Proc. Natl Acad. Sci. USA 108, 19204\u201319209 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"679_CR10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.gastro.2011.12.001","volume":"142","author":"BD White","year":"2012","unstructured":"White, B. D., Chien, A. J. & Dawson, D. W. Dysregulation of Wnt\/\u03b2-catenin signaling in gastrointestinal cancers. Gastroenterology 142, 219\u2013232 (2012).","journal-title":"Gastroenterology"},{"key":"679_CR11","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ceb.2007.02.007","volume":"19","author":"R Fodde","year":"2007","unstructured":"Fodde, R. & Brabletz, T. Wnt\/\u03b2-catenin signaling in cancer stemness and malignant behavior. Curr. Opin. Cell Biol. 19, 150\u2013158 (2007).","journal-title":"Curr. Opin. Cell Biol."},{"key":"679_CR12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ccr.2010.03.020","volume":"17","author":"H Zheng","year":"2010","unstructured":"Zheng, H., Ying, H., Wiedemeyer, R., Yan, H., Quayle, S. N., Ivanova, E. V. et al. PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell 17, 497\u2013509 (2010).","journal-title":"Cancer Cell"},{"key":"679_CR13","first-page":"1510","volume":"62","author":"K Hensen","year":"2002","unstructured":"Hensen, K., Van Valckenborgh, I. C., Kas, K., Van de Ven, W. J. & Voz, M. L. The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. Cancer Res. 62, 1510\u20131517 (2002).","journal-title":"Cancer Res."},{"key":"679_CR14","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood-2004-09-3630","volume":"105","author":"SF Landrette","year":"2005","unstructured":"Landrette, S. F., Kuo, Y. H., Hensen, K., Barjesteh, V. W. V. D., Perrat, P. N., Van de Ven, W. J. et al. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood 105, 2900\u20132907 (2005).","journal-title":"Blood"},{"key":"679_CR15","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/leu.2010.301","volume":"25","author":"SF Landrette","year":"2011","unstructured":"Landrette, S. F., Madera, D., He, F. & Castilla, L. H. The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells. Leukemia 25, 655\u2013662 (2011).","journal-title":"Leukemia"},{"key":"679_CR16","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/carcin\/bgu081","volume":"35","author":"R Sekiya","year":"2014","unstructured":"Sekiya, R., Maeda, M., Yuan, H., Asano, E., Hyodo, T., Hasegawa, H. et al. PLAGL2 regulates actin cytoskeletal architecture and cell migration. Carcinogenesis 35, 1993\u20132001 (2014).","journal-title":"Carcinogenesis"},{"key":"679_CR17","doi-asserted-by":"crossref","first-page":"e88126","DOI":"10.1371\/journal.pone.0088126","volume":"9","author":"M Klemke","year":"2014","unstructured":"Klemke, M., Muller, M. H., Wosniok, W., Markowski, D. N., Nimzyk, R., Helmke, B. M. et al. Correlated expression of HMGA2 and PLAG1 in thyroid tumors, uterine leiomyomas and experimental models. PLoS ONE 9, e88126 (2014).","journal-title":"PLoS ONE"},{"key":"679_CR18","first-page":"918","volume":"59","author":"AK Astrom","year":"1999","unstructured":"Astrom, A. K., Voz, M. L., Kas, K., Roijer, E., Wedell, B., Mandahl, N. et al. Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene. Cancer Res. 59, 918\u2013923 (1999).","journal-title":"Cancer Res."},{"key":"679_CR19","first-page":"3089","volume":"7","author":"B Liu","year":"2014","unstructured":"Liu, B., Lu, C., Song, Y. X., Gao, P., Sun, J. X., Chen, X. W. et al. The role of pleomorphic adenoma gene-like 2 in gastrointestinal cancer development, progression, and prognosis. Int. J. Clin. Exp. Pathol. 7, 3089\u20133100 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"679_CR20","doi-asserted-by":"crossref","first-page":"9961","DOI":"10.18632\/oncotarget.14283","volume":"8","author":"J Chen","year":"2017","unstructured":"Chen, J., Yuan, W., Wu, L., Tang, Q., Xia, Q., Ji, J. et al. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1\/Twist1 pathway. Oncotarget 8, 9961\u20139973 (2017).","journal-title":"Oncotarget"},{"key":"679_CR21","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1038\/onc.2016.339","volume":"36","author":"CC Liu","year":"2017","unstructured":"Liu, C. C., Cai, D. L., Sun, F., Wu, Z. H., Yue, B., Zhao, S. L. et al. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of \u03b2-catenin transcriptional activity. Oncogene 36, 1779\u20131792 (2017).","journal-title":"Oncogene"},{"key":"679_CR22","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1158\/0008-5472.CAN-18-1304","volume":"79","author":"L Ma","year":"2019","unstructured":"Ma, L., Lin, K., Chang, G., Chen, Y., Yue, C., Guo, Q. et al. Aberrant activation of \u03b2-catenin signaling drives glioma tumorigenesis via USP1-mediated stabilization of EZH2. Cancer Res. 79, 72\u201385 (2019).","journal-title":"Cancer Res."},{"key":"679_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D. et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1\u20136 (2004).","journal-title":"Neoplasia"},{"issue":"W1","key":"679_CR24","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z., Li, C., Kang, B., Gao, G., Li, C. & Zhang, Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45(W1), W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"679_CR25","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1158\/0008-5472.CAN-11-4038","volume":"72","author":"B Cieply","year":"2012","unstructured":"Cieply, B., Riley, P. 4th, Pifer, P. M., Widmeyer, J., Addison, J. B., Ivanov, A. V. et al. Suppression of the epithelial\u2013mesenchymal transition by Grainyhead-like-2. Cancer Res. 72, 2440\u20132453 (2012).","journal-title":"Cancer Res."},{"key":"679_CR26","doi-asserted-by":"crossref","first-page":"22993","DOI":"10.1074\/jbc.M113.456293","volume":"288","author":"S Werner","year":"2013","unstructured":"Werner, S., Frey, S., Riethdorf, S., Schulze, C., Alawi, M., Kling, L. et al. Dual roles of the transcription factor Grainyhead-like 2 (GRHL2) in breast cancer. J. Biol. Chem. 288, 22993\u20133008 (2013).","journal-title":"J. Biol. Chem."},{"key":"679_CR27","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1158\/0008-5472.CAN-12-4082","volume":"73","author":"B Cieply","year":"2013","unstructured":"Cieply, B., Farris, J., Denvir, J., Ford, H. L. & Frisch, S. M. Epithelial\u2013mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2. Cancer Res. 73, 6299\u20136309 (2013).","journal-title":"Cancer Res."},{"key":"679_CR28","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1002\/jcb.25974","volume":"118","author":"SM Mooney","year":"2017","unstructured":"Mooney, S. M., Talebian, V., Jolly, M. K., Jia, D., Gromala, M., Levine, H. et al. The GRHL2\/ZEB feedback loop\u2014a key axis in the regulation of EMT in breast cancer. J. Cell Biochem 118, 2559\u20132570 (2017).","journal-title":"J. Cell Biochem"},{"key":"679_CR29","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(07)60781-8","volume":"369","author":"SA Eccles","year":"2007","unstructured":"Eccles, S. A. & Welch, D. R. Metastasis: recent discoveries and novel treatment strategies. Lancet 369, 1742\u20131757 (2007).","journal-title":"Lancet"},{"key":"679_CR30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta, G. P. & Massague, J. Cancer metastasis: building a framework. Cell 127, 679\u2013695 (2006).","journal-title":"Cell"},{"key":"679_CR31","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","volume":"45","author":"NM Aiello","year":"2018","unstructured":"Aiello, N. M., Maddipati, R., Norgard, R. J., Balli, D., Li, J., Yuan, S. et al. EMT subtype influences epithelial plasticity and mode of cell migration. Dev Cell. 45, 681\u2013695 (2018).","journal-title":"Dev Cell."},{"key":"679_CR32","doi-asserted-by":"crossref","unstructured":"George, J. T., Jolly, M. K., Xu, S., Somarelli, J. A. & Levine, H. Survival out comes in cancer patients predicted by a partial EMT gene expression scoring metric. Cancer Res. 77, 6415\u20136428 (2017).","DOI":"10.1158\/0008-5472.CAN-16-3521"},{"key":"679_CR33","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1878-0261.12084","volume":"11","author":"MK Jolly","year":"2017","unstructured":"Jolly, M. K., Tripathi, S. C., Somarelli, J. A., Hanash, S. M. & Levine, H. Epithelial\/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding? Mol Oncol. 11, 739\u2013754 (2017).","journal-title":"Mol Oncol"},{"key":"679_CR34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.ctdb.2014.11.021","volume":"112","author":"P Savagner","year":"2015","unstructured":"Savagner, P. Epithelial\u2013mesenchymal transitions: from cell plasticity to concept elasticity. Curr Top Dev Biol. 112, 273\u2013300 (2015).","journal-title":"Curr Top Dev Biol"},{"key":"679_CR35","volume":"9","author":"J Zhou","year":"2018","unstructured":"Zhou, J., Liu, H., Zhang, L., Liu, X., Zhang, C., Wang, Y. et al. DJ-1 promotes colorectal cancer progression through activating PLAGL2\/Wnt\/BMP4 axis. Cell Death Dis. 9, 865 (2018).","journal-title":"Cell Death Dis."},{"key":"679_CR36","first-page":"897","volume":"1","author":"E Sanchez-Tillo","year":"2011","unstructured":"Sanchez-Tillo, E., Siles, L., de Barrios, O., Cuatrecasas, M., Vaquero, E. C., Castells, A. et al. Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am J. Cancer Res. 1, 897\u2013912 (2011).","journal-title":"Am J. Cancer Res."},{"key":"679_CR37","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/embor.2010.117","volume":"11","author":"S Brabletz","year":"2010","unstructured":"Brabletz, S. & Brabletz, T. The ZEB\/miR-200 feedback loop\u2013a motor of cellular plasticity in development and cancer? Embo Rep. 11, 670\u2013677 (2010).","journal-title":"Embo Rep."},{"key":"679_CR38","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ncb1998","volume":"11","author":"U Wellner","year":"2009","unstructured":"Wellner, U., Schubert, J., Burk, U. C., Schmalhofer, O., Zhu, F., Sonntag, A. et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 11, 1487\u20131495 (2009).","journal-title":"Nat Cell Biol."},{"key":"679_CR39","first-page":"3689","volume":"24","author":"D Senfter","year":"2015","unstructured":"Senfter, D., Holzner, S., Kalipciyan, M., Staribacher, A., Walzl, A., Huttary, N. et al. Loss of miR-200 family in 5-fluorouracil resistant colon cancer drives lymphendothelial invasiveness in vitro. Hum. Mol. Genet. 24, 3689\u20133698 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"679_CR40","doi-asserted-by":"crossref","first-page":"5054","DOI":"10.1158\/0008-5472.CAN-16-0246","volume":"76","author":"L Su","year":"2016","unstructured":"Su, L., Luo, Y., Yang, Z., Yang, J., Yao, C., Cheng, F. et al. MEF2D transduces microenvironment stimuli to ZEB1 to promote epithelial-mesenchymal transition and metastasis in colorectal cancer. Cancer Res. 76, 5054\u20135067 (2016).","journal-title":"Cancer Res."},{"key":"679_CR41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1158\/0008-5472.CAN-17-0883","volume":"78","author":"P Hou","year":"2018","unstructured":"Hou, P., Li, L., Chen, F., Chen, Y., Liu, H., Li, J. et al. PTBP3-mediated regulation of ZEB1 mRNA stability promotes epithelial-mesenchymal transition in breast cancer. Cancer Res. 78, 387\u2013398 (2018).","journal-title":"Cancer Res."},{"key":"679_CR42","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.cell.2012.11.026","volume":"151","author":"J Rosenbluh","year":"2012","unstructured":"Rosenbluh, J., Nijhawan, D., Cox, A. G., Li, X., Neal, J. T., Schafer, E. J. et al. \u03b2-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis. Cell 151, 1457\u20131473 (2012).","journal-title":"Cell"},{"key":"679_CR43","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/gutjnl-2011-301083","volume":"62","author":"S Ji","year":"2013","unstructured":"Ji, S., Ye, G., Zhang, J., Wang, L., Wang, T., Wang, Z. et al. miR-574-5p negatively regulates Qki6\/7 to impact \u03b2-catenin\/Wnt signalling and the development of colorectal cancer. Gut 62, 716\u2013726 (2013).","journal-title":"Gut"},{"key":"679_CR44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41556-018-0072-9","volume":"20","author":"M Romero","year":"2018","unstructured":"Romero, M., Sabate-Perez, A., Francis, V. A., Castrillon-Rodriguez, I., Diaz-Ramos, A., Sanchez-Feutrie, M. et al. TP53INP2 regulates adiposity by activating \u03b2-catenin through autophagy-dependent sequestration of GSK3\u03b2. Nat Cell Biol. 20, 443\u2013454 (2018).","journal-title":"Nat Cell Biol"},{"key":"679_CR45","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0848-3","volume":"17","author":"SB Uppada","year":"2018","unstructured":"Uppada, S. B., Gowrikumar, S., Ahmad, R., Kumar, B., Szeglin, B., Chen, X. et al. MASTL induces colon cancer progression and chemoresistance by promoting Wnt\/\u03b2-catenin signaling. Mol. Cancer 17, 111 (2018).","journal-title":"Mol. Cancer"},{"key":"679_CR46","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1158\/0008-5472.CAN-17-2683","volume":"78","author":"L Liu","year":"2018","unstructured":"Liu, L., Zhang, Y., Wong, C. C., Zhang, J., Dong, Y., Li, X. et al. RNF6 promotes colorectal cancer by activating the Wnt\/\u03b2-catenin pathway via ubiquitination of TLE3. Cancer Res. 78, 1958\u20131971 (2018).","journal-title":"Cancer Res."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0679-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0679-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0679-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:06:25Z","timestamp":1684616785000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0679-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,2,18]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1038\/s41416-019-0679-z","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]},"assertion":[{"value":"12 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments in our study were carried out in accordance with the Helsinki Declaration, and approved by the Ethics Committee Tongji Medical College, Huazhong University of Science and Technology (S-082\/2019). Patients were informed that the resected specimens were stored by the hospital and potentially used for scientific research, and that their privacy would be maintained. All patients provided informed consent prior to undergoing screening procedures. Our study protocol (S-082\/2019) was approved by the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology (Wuhan, China).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The datasets generated and\/or analysed during the current study are not publicly available but are available from the corresponding author on reasonable request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was supported by the National Natural Science Foundation of China (NSFC) (Grant numbers: 81271199 and 81772581).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}